Pharma major, Lupin Limited said that it has launched the generic Wellbutrin XL tablets in the United States, having received an approval from the United States Food and Drug Administration (FDA) earlier.
Bupropion Hydrochloride Extended-Release tablets USP (XL), 150 mg and 300 mg is the AB rated generic equivalent of Valeant Pharmaceuticals North America, LLC's Wellbutrin XL tablets, 150 mg and 300 mg, the company said in a filing to the Bombay Stock Exchange.
The drug is indicated for the treatment of major depressive disorder (MDD) and prevention of seasonal affective disorder (SAD) in adults.
As per IMS MAT May 2017, Wellbutrin XL tablets had US sales of $758 million.
Meanwhile, shares of the company were trading at Rs 1183.50 apiece, up 0.24 per cent from the previous close at 15:15 hours on BSE.